Article Views:
116
Ezine ready page
Ezine ready page
Posted on June 1, 2009 by Miss K | Posted under Legal
Defective Bard Avaulta Prompts Possible Lawsuits
|
One belief is that the Bard Avaulta surgical mesh design inhibits surrounding tissue from receiving nutrients and oxygen, causing impaired healing. This can lead to other complications that may require further surgery and painful side effects, such as infection. A transvaginal surgical mesh infection is a significant complication that can be very damaging to women who have an Avaulta surgical mesh. Infections from transvaginal placement of surgical mesh can occur in one of two ways. First, an infection may be caused by bowel, bladder, or blood vessel perforation, which occurs during insertion of the surgical mesh. Second, the surgical mesh design may inhibit surrounding tissue from receiving nutrients and oxygen, causing impaired healing that can lead to an infection. Of all the surgical mesh manufacturers, one of the major ones is C.R. Bard Inc. This company has a number of different transvaginal mesh products on the retail market to treat moderate to severe cases of stress urinary incontinence and pelvic organ prolapse. One of these products is the Avaulta Plus Biosynthetic Support System. These mesh products can be purchased as kits to use for anterior or posterior support, and can be planted as part of an outpatient procedure that can be performed in under an hour under local anesthesia. The mesh that is used for the Avaulta Plus Biosynthetic Support System is coated with collagen, while the ends of the sling are designed to provide strength and tension free attachment to the vaginal wall. Although these Bard Avaulta surgical mesh devices have been a popular surgical implantation, being cited by many physicians as the best cure for urinary stress incontinence and pelvic organ prolapse, a high percentage of the women that undergo these procedures experience serious complications due to the mesh that is used. Some patients may experience an allergic reaction shortly after the device has been implanted, while others experience complications and injuries due to the surgical procedure itself, such as damage to the bladder, the bowel, or the large blood vessels that are present in the pelvic area. The FDA issued a Public Health Notification on October 20, 2008 prompting calls for a Bard Avaulta transvaginal surgical mesh recall, after receiving more than 1,000 reports of complications associated with these devices. However, as of early 2009, no recall has been issued. About The Author: Consumer Injury Lawyers is a consumer advocacy website that provides up to date information and news about Bard Avaulta Mesh Lawsuits. |
Tags: TRANSVAGINAL SURGICAL MESH INFECTION, AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM, BARD AVAULTA TRANSVAGINAL SURGICAL MESH RECALL
